Revenue: As of FY2026 Q1, the actual value is USD 589.15 M, beating the estimate of USD 572.44 M.

EPS: As of FY2026 Q1, the actual value is USD -0.15, missing the estimate of USD 0.0033.

EBIT: As of FY2026 Q1, the actual value is USD 15.7 M.

First Quarter 2026 Financial Results

Net SalesEnovis Corporation reported first-quarter net sales of $589 million, representing a 5% increase on a reported basis and a 3% increase on an organic basis compared to the same quarter in 2025 .

Segment Revenue and Growth Reconstructive Segment: Net sales grew 11% on a reported basis to $317.1 million and 6% on an organic basis compared to $286.3 million in the first quarter of 2025 . Prevention and Recovery (P&R) Segment: Net sales were flat on a reported basis at $272.0 million and grew 1% on an organic basis compared to $272.6 million in the first quarter of 2025 .

Profitability Metrics (GAAP) Net Loss: The company reported a net loss of -$8,450 thousand for the first quarter of 2026, a significant improvement from the -$55,705 thousand net loss in the first quarter of 2025 . Net Loss Margin: The net loss margin was -1.4% of sales in Q1 2026, compared to -10.0% in Q1 2025 . Gross Profit: Gross profit for Q1 2026 was $365,485 thousand, up from $332,229 thousand in Q1 2025 . Gross Profit Margin: The gross profit margin was 62.0% in Q1 2026, an increase from 59.5% in Q1 2025 . Operating Income (Loss): Operating income was $6,530 thousand in Q1 2026, a substantial improvement from an operating loss of -$46,769 thousand in Q1 2025 . Operating Income (Loss) Margin: The operating income margin was 1.1% in Q1 2026, compared to an operating loss margin of -8.4% in Q1 2025 .

Profitability Metrics (Non-GAAP) Adjusted EBITDA: Adjusted EBITDA reached $103.6 million in Q1 2026, up from $87.1 million in Q1 2025 . Adjusted EBITDA Margin: The adjusted EBITDA margin was 17.6% of sales in Q1 2026, an increase from 15.6% in Q1 2025 . Adjusted Gross Profit: Adjusted gross profit was $366.1 million in Q1 2026, compared to $332.8 million in Q1 2025 . Adjusted Gross Profit Margin: The adjusted gross profit margin was 62.1% in Q1 2026, up from 59.6% in Q1 2025 . Adjusted Net Income: Adjusted net income from continuing operations was $51.6 million in Q1 2026, an increase from $37.3 million in Q1 2025 . Adjusted Net Income Margin: Adjusted net income margin was 8.8% in Q1 2026, up from 6.7% in Q1 2025 .

Cash Flow Net Cash Provided by Operating Activities: Net cash provided by operating activities was $23,951 thousand in Q1 2026, a significant improvement from net cash used in operating activities of -$1,596 thousand in Q1 2025 .

Key Expenses Cost of Sales: $223,666 thousand in Q1 2026 versus $226,605 thousand in Q1 2025 . Selling, General and Administrative Expense: $282,810 thousand in Q1 2026 versus $269,019 thousand in Q1 2025 . Research and Development Expense: $31,533 thousand in Q1 2026 versus $28,528 thousand in Q1 2025 . Amortization of Acquired Intangibles: $41,904 thousand in Q1 2026 versus $41,812 thousand in Q1 2025 . Restructuring Charges: $2,708 thousand in Q1 2026 versus $3,862 thousand in Q1 2025 . Interest Expense, Net: $9,169 thousand in Q1 2026 versus $9,188 thousand in Q1 2025 . Other (Income) Expense, Net: -$3,273 thousand in Q1 2026 versus $1,392 thousand in Q1 2025 . Income Tax Expense (Benefit): $9,045 thousand in Q1 2026 versus -$1,769 thousand in Q1 2025 . Stock-Based Compensation Expense: $8,750 thousand in Q1 2026 versus $7,407 thousand in Q1 2025 . Depreciation and Amortization: $73,355 thousand in Q1 2026 versus $71,435 thousand in Q1 2025 .

2026 Financial Outlook

Enovis Corporation reaffirms its financial expectations for 2026 . The company anticipates revenue to be approximately $2.31-2.37 billion, which includes an organic revenue growth of 4-6% . Adjusted EBITDA is projected to be in the range of $425-435 million, and full-year free cash flow conversion is expected to be 25% or higher .